Skip to main content
Top
Published in: Nuclear Medicine and Molecular Imaging 6/2020

01-12-2020 | Positron Emission Tomography | Original Article

Spatial Normalization Using Early-Phase [18F]FP-CIT PET for Quantification of Striatal Dopamine Transporter Binding

Authors: Sungwoo Bae, Hongyoon Choi, Wonseok Whi, Jin Chul Paeng, Gi Jeong Cheon, Keon Wook Kang, Dong Soo Lee

Published in: Nuclear Medicine and Molecular Imaging | Issue 6/2020

Login to get access

Abstract

Purpose

The precise quantification of dopamine transporter (DAT) density on N-(3-[18F]Fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl) nortropane positron emission tomography ([18F]FP-CIT PET) imaging is crucial to measure the degree of striatal DAT loss in patients with parkinsonism. The quantitative analysis requires a spatial normalization process based on a template brain. Since the spatial normalization method based on a delayed-phase PET has limited performance, we suggest an early-phase PET-based method and compared its accuracy, referring to the MRI-based approach as a gold standard.

Methods

A total of 39 referred patients from the movement disorder clinic who underwent dual-phase [18F]FP-CIT PET and took MRI within 1 year were retrospectively analyzed. The three spatial normalization methods were applied for quantification of [18F]FP-CIT PET-MRI-based anatomical normalization, PET template-based method based on delayed PET, and that based on early PET. The striatal binding ratios (BRs) were compared, and voxelwise paired t tests were implemented between different methods.

Results

The early image-based normalization showed concordant patterns of putaminal [18F]FP-CIT binding with an MRI-based method. The BRs of the putamen from the MRI-based approach showed higher agreement with early image- than delayed image-based method as presented by Bland-Altman plots and intraclass correlation coefficients (early image-based, 0.980; delayed image-based, 0.895). The voxelwise test exhibited a smaller volume of significantly different counts in putamen between brains processed by early image and MRI compared to that between delayed image and MRI.

Conclusion

The early-phase [18F]FP-CIT PET can be utilized for spatial normalization of delayed PET image when the MRI image is unavailable and presents better performance than the delayed template-based method in quantitation of putaminal binding ratio.
Literature
1.
go back to reference Palermo G, Ceravolo R. Molecular imaging of the dopamine transporter. Cells. 2019;8:872.CrossRef Palermo G, Ceravolo R. Molecular imaging of the dopamine transporter. Cells. 2019;8:872.CrossRef
2.
go back to reference Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, et al. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy. J Nucl Med. 2012;53:399–406.CrossRef Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, et al. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy. J Nucl Med. 2012;53:399–406.CrossRef
3.
go back to reference Ba F, Martin WW. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice. Parkinsonism Relat Disord. 2015;21:87–94.CrossRef Ba F, Martin WW. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice. Parkinsonism Relat Disord. 2015;21:87–94.CrossRef
4.
go back to reference Hong CM, Ryu HS, Ahn BC. Early perfusion and dopamine transporter imaging using 18F-FP-CIT PET/CT in patients with parkinsonism. Am J Nucl Med Mol Imaging. 2018;8:360–72.PubMedPubMedCentral Hong CM, Ryu HS, Ahn BC. Early perfusion and dopamine transporter imaging using 18F-FP-CIT PET/CT in patients with parkinsonism. Am J Nucl Med Mol Imaging. 2018;8:360–72.PubMedPubMedCentral
5.
go back to reference Kazumata K, Dhawan V, Chaly T, Antonini A, Margouleff C, Belakhlef A, et al. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med. 1998;39:1521–30.PubMed Kazumata K, Dhawan V, Chaly T, Antonini A, Margouleff C, Belakhlef A, et al. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med. 1998;39:1521–30.PubMed
6.
go back to reference Lee I, Kim JS, Park JY, Byun BH, Park SY, Choi JH, et al. Head-to-head comparison of 18F-FP-CIT and 123I-FP-CIT for dopamine transporter imaging in patients with Parkinson's disease: a preliminary study. Synapse. 2018;72:e22032.CrossRef Lee I, Kim JS, Park JY, Byun BH, Park SY, Choi JH, et al. Head-to-head comparison of 18F-FP-CIT and 123I-FP-CIT for dopamine transporter imaging in patients with Parkinson's disease: a preliminary study. Synapse. 2018;72:e22032.CrossRef
7.
go back to reference Ashburner J, Friston KJ. Voxel-based morphometry--the methods. Neuroimage. 2000;11:805–21.CrossRef Ashburner J, Friston KJ. Voxel-based morphometry--the methods. Neuroimage. 2000;11:805–21.CrossRef
8.
go back to reference Crinion J, Ashburner J, Leff A, Brett M, Price C, Friston K. Spatial normalization of lesioned brains: performance evaluation and impact on fMRI analyses. Neuroimage. 2007;37:866–75.CrossRef Crinion J, Ashburner J, Leff A, Brett M, Price C, Friston K. Spatial normalization of lesioned brains: performance evaluation and impact on fMRI analyses. Neuroimage. 2007;37:866–75.CrossRef
9.
go back to reference Gispert JD, Pascau J, Reig S, Martinez-Lazaro R, Molina V, Garcia-Barreno P, et al. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans. Neuroimage. 2003;19:601–12.CrossRef Gispert JD, Pascau J, Reig S, Martinez-Lazaro R, Molina V, Garcia-Barreno P, et al. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans. Neuroimage. 2003;19:601–12.CrossRef
10.
go back to reference Kim YI, Im HJ, Paeng JC, Lee JS, Eo JS, Kim DH, et al. Validation of simple quantification methods for 18F-FP-CIT PET using automatic delineation of volumes of interest based on statistical probabilistic anatomical mapping and isocontour margin setting. Nucl Med Mol Imaging. 2012;46:254–60.CrossRef Kim YI, Im HJ, Paeng JC, Lee JS, Eo JS, Kim DH, et al. Validation of simple quantification methods for 18F-FP-CIT PET using automatic delineation of volumes of interest based on statistical probabilistic anatomical mapping and isocontour margin setting. Nucl Med Mol Imaging. 2012;46:254–60.CrossRef
11.
go back to reference Kim JS, Cho H, Choi JY, Lee SH, Ryu YH, Lyoo CH, et al. Feasibility of computed tomography-guided methods for spatial normalization of dopamine transporter positron emission tomography image. PLoS One. 2015;10:e0132585.CrossRef Kim JS, Cho H, Choi JY, Lee SH, Ryu YH, Lyoo CH, et al. Feasibility of computed tomography-guided methods for spatial normalization of dopamine transporter positron emission tomography image. PLoS One. 2015;10:e0132585.CrossRef
12.
go back to reference Jin S, Oh M, Oh SJ, Oh JS, Lee SJ, Chung SJ, et al. Differential diagnosis of parkinsonism using dual-phase F-18 FP-CIT PET imaging. Nucl Med Mol Imaging. 2013;47:44–51.CrossRef Jin S, Oh M, Oh SJ, Oh JS, Lee SJ, Chung SJ, et al. Differential diagnosis of parkinsonism using dual-phase F-18 FP-CIT PET imaging. Nucl Med Mol Imaging. 2013;47:44–51.CrossRef
13.
go back to reference Jin S, Oh M, Oh SJ, Oh JS, Lee SJ, Chung SJ, et al. Additional value of early-phase 18F-FP-CIT PET image for differential diagnosis of atypical parkinsonism. Clin Nucl Med. 2017;42:e80–e7.CrossRef Jin S, Oh M, Oh SJ, Oh JS, Lee SJ, Chung SJ, et al. Additional value of early-phase 18F-FP-CIT PET image for differential diagnosis of atypical parkinsonism. Clin Nucl Med. 2017;42:e80–e7.CrossRef
14.
go back to reference Min JH, Park DG, Yoon JH, An YS. Dual-phase 18F-FP-CIT PET in corticobasal syndrome. Clin Nucl Med. 2019;44:e49–50.CrossRef Min JH, Park DG, Yoon JH, An YS. Dual-phase 18F-FP-CIT PET in corticobasal syndrome. Clin Nucl Med. 2019;44:e49–50.CrossRef
15.
go back to reference Yoon JH, Ahn YS. Dual-phase 18F-FP-CIT PET in corticobasal syndrome underlying AD pathology. Eur J Nucl Med Mol Imaging. 2019;46:2208–9.CrossRef Yoon JH, Ahn YS. Dual-phase 18F-FP-CIT PET in corticobasal syndrome underlying AD pathology. Eur J Nucl Med Mol Imaging. 2019;46:2208–9.CrossRef
16.
go back to reference Jeong E, Oh SY, Pahk K, Lee CN, Park KW, Lee JS, et al. Feasibility of PET template-based analysis on F-18 FP-CIT PET in patients with De novo Parkinson’s disease. Nucl Med Mol Imaging. 2013;47:73–80.CrossRef Jeong E, Oh SY, Pahk K, Lee CN, Park KW, Lee JS, et al. Feasibility of PET template-based analysis on F-18 FP-CIT PET in patients with De novo Parkinson’s disease. Nucl Med Mol Imaging. 2013;47:73–80.CrossRef
17.
go back to reference Ma Y, Dhawan V, Mentis M, Chaly T, Spetsieris PG, Eidelberg D. Parametric mapping of [18F] FPCIT binding in early stage Parkinson’s disease: a PET study. Synapse. 2002;45:125–33.CrossRef Ma Y, Dhawan V, Mentis M, Chaly T, Spetsieris PG, Eidelberg D. Parametric mapping of [18F] FPCIT binding in early stage Parkinson’s disease: a PET study. Synapse. 2002;45:125–33.CrossRef
18.
go back to reference Hsiao IT, Huang CC, Hsieh CJ, Hsu WC, Wey SP, Yen TC, et al. Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies. Eur J Nucl Med Mol Imaging. 2012;39:613–20.CrossRef Hsiao IT, Huang CC, Hsieh CJ, Hsu WC, Wey SP, Yen TC, et al. Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies. Eur J Nucl Med Mol Imaging. 2012;39:613–20.CrossRef
19.
go back to reference Hsiao T, Huang CC, Hsieh CJ, Wey SP, Kung MP, Yen TC, et al. Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45/Amyvid) PET. Eur J Nucl Med Mol Imaging. 2013;40:908–20.CrossRef Hsiao T, Huang CC, Hsieh CJ, Wey SP, Kung MP, Yen TC, et al. Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45/Amyvid) PET. Eur J Nucl Med Mol Imaging. 2013;40:908–20.CrossRef
20.
go back to reference Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Scholl M, et al. Comparison of early-phase 11C-deuterium-l-deprenyl and 11C-Pittsburgh compound B PET for assessing brain perfusion in Alzheimer disease. J Nucl Med. 2016;57:1071–7.CrossRef Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Scholl M, et al. Comparison of early-phase 11C-deuterium-l-deprenyl and 11C-Pittsburgh compound B PET for assessing brain perfusion in Alzheimer disease. J Nucl Med. 2016;57:1071–7.CrossRef
21.
go back to reference Daerr S, Brendel M, Zach C, Mille E, Schilling D, Zacherl MJ, et al. Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases. Neuroimage Clin. 2017;14:77–86.CrossRef Daerr S, Brendel M, Zach C, Mille E, Schilling D, Zacherl MJ, et al. Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases. Neuroimage Clin. 2017;14:77–86.CrossRef
Metadata
Title
Spatial Normalization Using Early-Phase [18F]FP-CIT PET for Quantification of Striatal Dopamine Transporter Binding
Authors
Sungwoo Bae
Hongyoon Choi
Wonseok Whi
Jin Chul Paeng
Gi Jeong Cheon
Keon Wook Kang
Dong Soo Lee
Publication date
01-12-2020
Publisher
Springer Singapore
Published in
Nuclear Medicine and Molecular Imaging / Issue 6/2020
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-020-00669-0

Other articles of this Issue 6/2020

Nuclear Medicine and Molecular Imaging 6/2020 Go to the issue